{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T04:08:05Z","timestamp":1769659685759,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T00:00:00Z","timestamp":1352764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s13277-012-0573-2","type":"journal-article","created":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T00:22:54Z","timestamp":1352679774000},"page":"481-491","source":"Crossref","is-referenced-by-count":65,"title":["MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Martina","family":"Redova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandr","family":"Poprach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Besse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Iliev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Nekvindova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"Lakomy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Radova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Svoboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Dolezel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rostislav","family":"Vyzula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Slaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,13]]},"reference":[{"key":"573_CR1","first-page":"1567","volume-title":"Campbell-Wals Urology","author":"SC Campbell","year":"2007","unstructured":"Campbell SC, Novick AC, Bukowski RM. Renal tumors. In: Wein AJ, Kavoussi LR, Novick AC, et al., editors. Campbell-Wals Urology. 9th ed. Philadelphia: Saunders; 2007. p. 1567\u2013637.","edition":"9"},{"key":"573_CR2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704\u201314.","journal-title":"Nat Rev Genet"},{"key":"573_CR3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642\u201355.","journal-title":"Cell"},{"key":"573_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-863-8_1","volume":"676","author":"J Winter","year":"2011","unstructured":"Winter J, Diederichs S. MicroRNA biogenesis and cancer. Methods Mol Biol. 2011;676:3\u201322.","journal-title":"Methods Mol Biol"},{"key":"573_CR5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.clinbiochem.2009.07.020","volume":"43","author":"TF Chow","year":"2010","unstructured":"Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem. 2010;43:150\u20138.","journal-title":"Clin Biochem"},{"key":"573_CR6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/path.2437","volume":"216","author":"C Nakada","year":"2008","unstructured":"Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol. 2008;216:418\u201327.","journal-title":"J Pathol"},{"key":"573_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1756-9966-29-90","volume":"29","author":"O Slaby","year":"2010","unstructured":"Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, et al. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res. 2010;29:90.","journal-title":"J Exp Clin Cancer Res"},{"key":"573_CR8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/cbt.7.2.5297","volume":"7","author":"A Giannakakis","year":"2008","unstructured":"Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, et al. MiR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther. 2008;7:255\u201364.","journal-title":"Cancer Biol Ther"},{"key":"573_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1741-7015-8-65","volume":"8","author":"NM White","year":"2010","unstructured":"White NM, Yousef GM. MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. BMC Med. 2010;8:65.","journal-title":"BMC Med"},{"key":"573_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0076-6879(06)11008-3","volume":"411","author":"M Reimers","year":"2006","unstructured":"Reimers M, Carey VJ. Bioconductor: an open source framework for bioinformatics and computational biology. Methods Enzymol. 2006;411:119\u201334.","journal-title":"Methods Enzymol"},{"key":"573_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1476-4598-8-102","volume":"8","author":"O Slaby","year":"2009","unstructured":"Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer. 2009;8:102.","journal-title":"Mol Cancer"},{"key":"573_CR12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbrc.2011.01.019","volume":"405","author":"M Redova","year":"2011","unstructured":"Redova M, Svoboda M, Slaby O. MicroRNAs and their target gene networks in renal cell carcinoma. Biochem Biophys Res Commun. 2011;405:153\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"573_CR13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/0008-5472.CAN-06-3667","volume":"67","author":"Y Chen","year":"2007","unstructured":"Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007;67:976\u201383.","journal-title":"Cancer Res"},{"key":"573_CR14","doi-asserted-by":"crossref","first-page":"e15224","DOI":"10.1371\/journal.pone.0015224","volume":"5","author":"L Zhou","year":"2010","unstructured":"Zhou L, Chen J, Li Z, Li X, Hu X, Huang Y, et al. Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One. 2010;5:e15224.","journal-title":"PLoS One"},{"key":"573_CR15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00345-010-0633-4","volume":"29","author":"J Heinzelmann","year":"2011","unstructured":"Heinzelmann J, Henning B, Sanjmyatav J, Posorski N, Steiner T, Wunderlich H, et al. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World Urol. 2011;29:367\u201373.","journal-title":"World Urol"},{"key":"573_CR16","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1194\/jlr.M004531","volume":"51","author":"KH Song","year":"2010","unstructured":"Song KH, Li T, Owsley E, Chiang JY. A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes. J Lipid Res. 2010;51:2223\u201333.","journal-title":"J Lipid Res"},{"key":"573_CR17","first-page":"160","volume":"310","author":"Y Xu","year":"2011","unstructured":"Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z, et al. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett. 2011;310:160\u20139.","journal-title":"Cancer Lett"},{"key":"573_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS20100297","volume":"120","author":"J Gui","year":"2011","unstructured":"Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond). 2011;120:183\u201393.","journal-title":"Clin Sci (Lond)"},{"key":"573_CR19","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/sj.onc.1210186","volume":"26","author":"R Garzon","year":"2007","unstructured":"Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2007;26:4148\u201357.","journal-title":"Oncogene"},{"key":"573_CR20","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr2257","volume":"11","author":"AJ Lowery","year":"2009","unstructured":"Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2\/neu receptor status in breast cancer. Breast Cancer Res. 2009;11:R27.","journal-title":"Breast Cancer Res"},{"key":"573_CR21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ejso.2009.04.010","volume":"35","author":"Y Huang","year":"2009","unstructured":"Huang Y, Dai Y, Yang J, Chen T, Yin Y, Tang M, et al. Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol. 2009;35:1119\u201323.","journal-title":"Eur J Surg Oncol"},{"key":"573_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/pr1011137","volume":"10","author":"B Seliger","year":"2011","unstructured":"Seliger B, Jasinski S, Dressler SP, Marincola FM, Recktenwald CV, Wang E, Lichtenfels R. Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma? J Proteome Res. 2011;10:191\u20139.","journal-title":"J Proteome Res"},{"key":"573_CR23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.juro.2011.04.110","volume":"186","author":"NM White","year":"2011","unstructured":"White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, et al. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol. 2011;186:1077\u201383.","journal-title":"J Urol"},{"key":"573_CR24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7150\/jca.2.515","volume":"2","author":"VA Valera","year":"2011","unstructured":"Valera VA, Walter BA, Linehan WM, Merino MJ. Regulatory effects of microRNA-92 (miR-92) on VHL gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma. J Cancer. 2011;2:515\u201326.","journal-title":"J Cancer"},{"key":"573_CR25","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4161\/cc.9.6.11006","volume":"9","author":"SY Chan","year":"2011","unstructured":"Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle. 2011;9:1072\u201383.","journal-title":"Cell Cycle"},{"key":"573_CR26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/path.2860","volume":"224","author":"C Nakada","year":"2011","unstructured":"Nakada C, Tsukamoto Y, Matsuura K, Nguyen TL, Hijiya N, Uchida T, et al. Overexpression of miR-210, a downstream target of HIF1\u03b1, causes centrosome amplification in renal carcinoma cells. J Pathol. 2011;224:280\u20138.","journal-title":"J Pathol"},{"key":"573_CR27","doi-asserted-by":"crossref","first-page":"e20980","DOI":"10.1371\/journal.pone.0020980","volume":"6","author":"F Roth\u00e9","year":"2011","unstructured":"Roth\u00e9 F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, Majjaj S, et al. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One. 2011;6:e20980.","journal-title":"PLoS One"},{"key":"573_CR28","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4161\/cc.8.17.9387","volume":"8","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Sun H, Dai H, Walsh RM, Imakura M, Schelter J, et al. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle. 2009;8:2756\u201368.","journal-title":"Cell Cycle"},{"key":"573_CR29","doi-asserted-by":"crossref","first-page":"15878","DOI":"10.1074\/jbc.M800731200","volume":"283","author":"P Fasanaro","year":"2008","unstructured":"Fasanaro P, D\u2019Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. J Biol Chem. 2008;283:15878\u201383.","journal-title":"J Biol Chem"},{"key":"573_CR30","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/MCB.01242-10","volume":"31","author":"TJ Kelly","year":"2011","unstructured":"Kelly TJ, Souza AL, Clish CB, Puigserver P. A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol. 2011;31:2696\u2013706.","journal-title":"Mol Cell Biol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-012-0573-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-012-0573-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-012-0573-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:24:47Z","timestamp":1559474687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-012-0573-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1007\/s13277-012-0573-2","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,13]]}}}